BI 2536

Catalog No.S1109

BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM in a cell-free assay. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.

Price Stock Quantity  
USD 240 In stock
USD 120 In stock
USD 210 In stock
USD 670 In stock
USD 997 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

BI 2536 Chemical Structure

BI 2536 Chemical Structure
Molecular Weight: 521.66

Validation & Quality Control

Cited by 52 publications:

10 customer reviews :

Quality Control & MSDS

Related Compound Libraries

PLK Inhibitors with Unique Features

  • Selective Plk Inhibitors

    GSK461364 Plk1-selective, Ki=2.2 nM.

  • Plk Inhibitor in Clinical Trial

    Rigosertib (ON-01910) Phase III for Myelo Dysplastic Syndrome (MDS).

  • Newest Plk Inhibitor

    Ro3280 Potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.

  • Calssic Plk Inhibitor

    Volasertib (BI 6727) Highly potent Plk1 inhibitor with IC50 of 0.87 nM and in phase II trials.

Product Information

  • Compare PLK Inhibitors
    Compare PLK Products
  • Research Area
  • Inhibition Profile
  • BI 2536 Mechanism

Product Description

Biological Activity

Description BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM in a cell-free assay. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.
Targets PLK1 [1]
(Cell-free assay)
PLK2 [1]
(Cell-free assay)
PLK3 [1]
(Cell-free assay)
PI3Kα [1]
(Cell-free assay)

 View  More

IC50 0.83 nM 3.5 nM 9.0 nM 2.407 μM
In vitro BI 2536 blocks the activities of Plk2 and Plk3 to a slightly lesser extent with IC50 of 3.5 nM and 9.0 nM, respectively. In HeLa cells, BI 2536 treatment ranging from 10-100 nM leads to the blocking of the recruitment of γ-tubulin and phosphorylation of Apc6 at mitotic centrosomes, inhibition of cohesin release from chromosome arms, induction of monopolar spindles, as well as a range of other mitotic processes that are known to depend on Plk1. BI 2536 treatment leads to the HeLa cells arrested in G2/M, subsequently a sub-G1 DNA peak indicative of DNA breakdown and apoptosis, and accumulated cleaved PARP p85 fragments in a concentration-dependent manner. BI 2536 inhibits the growth of a panel of 32 human cancer cell lines with EC50 of 2-25 nM, while blocking the proliferation of exponentially growing hTERT-RPE1, human umbilical vein endothelial cells (HUVECs), and normal rat kidney (NRK) cells with EC50 of 12-31 nM. [1] Plk1 inhibition by BI 2536 reduces the growth and viability of anaplastic thyroid carcinoma (ATC) cells such as CAL62, OCUT-1, SW1736, 8505C, and ACT-1 with EC50 values of 1.4-5.6 nM. [2]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
PSN1M3nrZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{HWOmlEPTB;MD6wNFc4PiEQvF2=MmDBV2FPT0WU
ACNNVH4NGVyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH2zb5dKSzVyPUCuNFA5PDNizszNM2P5PHNCVkeHUh?=
TE-8NHP6VGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTBwMEC5OFEh|ryPMkHSV2FPT0WU
LC-2-adM1m1Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mme2TWM2OD1yLkCxNFk{KM7:TR?=NFLwNnhUSU6JRWK=
ALL-POMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTBwMEGzJO69VQ>?MoW1V2FPT0WU
EW-16NYWxNINJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MknXTWM2OD1yLkCxN|M3KM7:TR?=MUXTRW5ITVJ?
KM12NUHObZFOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mmf3TWM2OD1yLkCxN|Q5KM7:TR?=M2DGWXNCVkeHUh?=
GI-1NFXo[GtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXvTWM2OD1yLkCxN|g{KM7:TR?=MXTTRW5ITVJ?
LS-411NM2jHVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NELwR|hKSzVyPUCuNFE1ODdizszNMn7tV2FPT0WU
ES8NXzwUHlOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvL[mRwUUN3ME2wMlAyPDl2IN88US=>MXTTRW5ITVJ?
SNU-C2BNVXoZ|ZlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTBwMEG1NlYh|ryPM4nidHNCVkeHUh?=
CESSMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlywTWM2OD1yLkCxOlAzKM7:TR?=MlzuV2FPT0WU
697NHLHeY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2XXRmlEPTB;MD6wNVY3QCEQvF2=Ml70V2FPT0WU
NCI-H1963MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEjHNnNKSzVyPUCuNFE3PzNizszNMXfTRW5ITVJ?
IA-LMM2XFZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTBwMEG2PFgh|ryPMnzyV2FPT0WU
SW954M{[wSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTBwMEG3NFUh|ryPNIPIPGxUSU6JRWK=
RL95-2NF;hPHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1fae2lEPTB;MD6wNVc{QCEQvF2=NFu5S45USU6JRWK=
LXF-289NHq3V2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3Hi[2lEPTB;MD6wNVc4KM7:TR?=MVPTRW5ITVJ?
OCUB-MNX3EUXBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRTBwMEG4NlYh|ryPMlv1V2FPT0WU
RKOMoCzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYr2dmtYUUN3ME2wMlAyQTh5IN88US=>NH;kWWRUSU6JRWK=
LOUCYM4rFZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGrBUVlKSzVyPUCuNFIxPSEQvF2=MXrTRW5ITVJ?
NOS-1M2HqWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmW5TWM2OD1yLkCyNFk{KM7:TR?=M3zMZXNCVkeHUh?=
A4-FukMke1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHjTWM2OD1yLkCyNlE5KM7:TR?=NUD3R2U{W0GQR1XS
A388NHm3XIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnUOmZKSzVyPUCuNFIzOjdizszNMlfGV2FPT0WU
TE-9M1;UWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVvhdJlQUUN3ME2wMlAzOjZzIN88US=>NWrZNnFEW0GQR1XS
KURAMOCHIMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHJR|UxRTBwMEKyPFUh|ryPMUnTRW5ITVJ?
KALS-1MlHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHnXZ5lKSzVyPUCuNFI{OzhizszNMVPTRW5ITVJ?
HOP-62MknGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEP2cm9KSzVyPUCuNFI1OiEQvF2=NIrVVIJUSU6JRWK=
RPMI-8402NH23ZXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4Ta[WlEPTB;MD6wNlUxQCEQvF2=MmHMV2FPT0WU
TE-1NGfZe3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1j4[GlEPTB;MD6wNlUyOiEQvF2=NEPzUZlUSU6JRWK=
CCRF-CEMMn[0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnS[2JKSzVyPUCuNFI2PDNizszNMoG4V2FPT0WU
HUTU-80Mnf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXri[pFTUUN3ME2wMlAzPjJ2IN88US=>Ml\HV2FPT0WU
NCI-H1648NUDwd4NsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTBwMEK2OFch|ryPNGnpXlNUSU6JRWK=
HCE-4MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PORWlEPTB;MD6wNlY5OiEQvF2=M4n0VnNCVkeHUh?=
ETK-1M3[3RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHSzU3VKSzVyPUCuNFI4OzZizszNMmTXV2FPT0WU
TE-15NITaO4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkDtTWM2OD1yLkCyO|M5KM7:TR?=NGHIOmhUSU6JRWK=
BE-13MnvhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MorWTWM2OD1yLkCyO|Qh|ryPMVHTRW5ITVJ?
KE-37NInYUHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPQOnh[UUN3ME2wMlAzPzRzIN88US=>NWm5OYJNW0GQR1XS
NCI-H1355NX20fIpOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;WZWlEPTB;MD6wNlc5OyEQvF2=MlT2V2FPT0WU
TE-11NFrKU4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUXJR|UxRTBwMEK4NFkh|ryPM2fvc3NCVkeHUh?=
BL-70MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIfRZXZKSzVyPUCuNFI5PTdizszNMXPTRW5ITVJ?
ES6NVj1WJRwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk[zTWM2OD1yLkCyPFgyKM7:TR?=MnvIV2FPT0WU
GT3TKBM3P0cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2HRNWlEPTB;MD6wNlk2OyEQvF2=Ml\HV2FPT0WU
LB647-SCLCNH\uOnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXlZ3hKSzVyPUCuNFMyQTVizszNNI\jN2lUSU6JRWK=
NB13NVzjWoliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIOxXohKSzVyPUCuNFM{OTZizszNMlP4V2FPT0WU
ST486MmLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTBwMEOzN|ch|ryPNWnIXZJQW0GQR1XS
NCI-H82MojFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlK3TWM2OD1yLkCzN|Q{KM7:TR?=NYfQbot3W0GQR1XS
NTERA-S-cl-D1NEPIc5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIDUOlZKSzVyPUCuNFM{QTlizszNMlP1V2FPT0WU
ES4MlfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlyyTWM2OD1yLkCzOFY{KM7:TR?=NYHRfHdyW0GQR1XS
SK-NEP-1NY\vXnZVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTHUohvUUN3ME2wMlA{PDl7IN88US=>MlvCV2FPT0WU
BeckerM3nHUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDufoMxUUN3ME2wMlA{PTV3IN88US=>NW\CbWZGW0GQR1XS
A101DNHLnNZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4S5dGlEPTB;MD6wN|c1QCEQvF2=Mo\CV2FPT0WU
SK-UT-1Ml7hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTBwMEO3O|Qh|ryPMYDTRW5ITVJ?
SW982NEjwVoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfjbFV2UUN3ME2wMlA{PzlizszNMWrTRW5ITVJ?
TE-10M4\TNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTBwMESwOFYh|ryPMXTTRW5ITVJ?
OVCAR-4NInRSXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1voS2lEPTB;MD6wOFA2QSEQvF2=MXfTRW5ITVJ?
KP-N-YSNXzB[3NOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTKS4Y3UUN3ME2wMlA1ODh3IN88US=>NHXUd2ZUSU6JRWK=
BL-41NEnmRpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXUcopKSzVyPUCuNFQyOjVizszNMX;TRW5ITVJ?
MZ1-PCMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XMO2lEPTB;MD6wOFEzPyEQvF2=M4TVUnNCVkeHUh?=
PF-382MojvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NETBTlVKSzVyPUCuNFQyQThizszNNH;EUolUSU6JRWK=
MOLT-13NYH5Tpp5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPtTWM2OD1yLkC0NlM5KM7:TR?=NF\ieJNUSU6JRWK=
HCC1599NYCze|Q6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\CXYlSUUN3ME2wMlA1OjV6IN88US=>NWjYbnZEW0GQR1XS
IST-MEL1MlfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2nwTGlEPTB;MD6wOFQ1OiEQvF2=M1;IfnNCVkeHUh?=
LU-139MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkfJTWM2OD1yLkC0OFQzKM7:TR?=MnXXV2FPT0WU
MS-1NWTsPHdQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnHXo1KSzVyPUCuNFQ4ODFizszNNEGwfmNUSU6JRWK=
MFH-inoNYrpWJFOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTBwMEWwNFMh|ryPMlmxV2FPT0WU
IMR-5MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NW\kTWw1UUN3ME2wMlA2ODJzIN88US=>M3PpfnNCVkeHUh?=
TE-5M4joPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1jOXmlEPTB;MD6wOVA3OyEQvF2=NH\wUVlUSU6JRWK=
DJM-1M4rseWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTBwMEWxOFIh|ryPNGHNRlRUSU6JRWK=
NB17MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzsblUxUUN3ME2wMlA2OjB5IN88US=>NXv3RXIxW0GQR1XS
KARPAS-45MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXThVIxvUUN3ME2wMlA2OzV6IN88US=>NGm5SlZUSU6JRWK=
TGBC1TKBMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;Ud2lEPTB;MD6wOVQxPSEQvF2=MVPTRW5ITVJ?
ML-2NILUbZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITqRm5KSzVyPUCuNFU1OTRizszNNUO0NmpzW0GQR1XS
no-10NIPjW|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTBwMEW0O|Qh|ryPMkjaV2FPT0WU
CTV-1MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnD[HJKSzVyPUCuNFU2ODJizszNNIjrUHRUSU6JRWK=
SJSA-1NGXWdJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoTZTWM2OD1yLkC1OVIh|ryPMljBV2FPT0WU
HC-1MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Moi5TWM2OD1yLkC1OVk4KM7:TR?=NIToXG9USU6JRWK=
TE-12NILhOFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX3m[lg{UUN3ME2wMlA2PjF|IN88US=>MUDTRW5ITVJ?
KY821MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPHe2xKSzVyPUCuNFU3OzJizszNNV6yfVY6W0GQR1XS
TALL-1M1ywPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVq0[o03UUN3ME2wMlA2PzB6IN88US=>NV7Gb2c5W0GQR1XS
DELNInoc25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzpTWM2OD1yLkC1O|A6KM7:TR?=M2L4S3NCVkeHUh?=
TE-6M1ixTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fUOWlEPTB;MD6wOVczOiEQvF2=NV7WOmR{W0GQR1XS
SK-LMS-1MoDTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4q0PWlEPTB;MD6wOVgxPSEQvF2=NYrFeYtjW0GQR1XS
EW-1MnywS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTBwMEW4N|ch|ryPMkXTV2FPT0WU
8-MG-BANGqwWHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;hZWdKSzVyPUCuNFU5PTFizszNNWGyNJliW0GQR1XS
NALM-6NH;MbYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{\kXGlEPTB;MD6wOVk4OyEQvF2=Ml;KV2FPT0WU
LB771-HNCNXX0WZg5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPrTWM2OD1yLkC1PVc6KM7:TR?=NU\UTZh1W0GQR1XS
HT-144M2\OZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTBwME[xN{DPxE1?M3rZXnNCVkeHUh?=
KM-H2M1u5OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;KU3YzUUN3ME2wMlA3OjJzIN88US=>NYDCT|kzW0GQR1XS
SF268MorRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYrJR|UxRTBwME[yPFYh|ryPNHLpeJlUSU6JRWK=
RS4-11MlzKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mki1TWM2OD1yLkC2N|A1KM7:TR?=NWPRNWtGW0GQR1XS
MHH-PREB-1NHv5bJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoWzTWM2OD1yLkC2N|E6KM7:TR?=NGXEOJRUSU6JRWK=
ATN-1M3[xNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlTDTWM2OD1yLkC2N|Q2KM7:TR?=MV;TRW5ITVJ?
BB30-HNCMmXFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTBwME[0N|Yh|ryPNUO5XHJ{W0GQR1XS
CPC-NM1jhO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTBwME[1NlQh|ryPMn75V2FPT0WU
NB1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTBwME[2NVMh|ryPM3HGcnNCVkeHUh?=
KS-1MlrSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPHTWM2OD1yLkC2O|Q5KM7:TR?=NXm1O2F1W0GQR1XS
RXF393Mn7WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTBwME[3OlQh|ryPNXHVbppOW0GQR1XS
IST-SL2M3H2WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWPYXlBLUUN3ME2wMlA4ODB2IN88US=>NVjkPIlCW0GQR1XS
GI-ME-NNIXZblhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\OfHVKSzVyPUCuNFczQDZizszNM3PvenNCVkeHUh?=
VA-ES-BJNFjoO2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mkf6TWM2OD1yLkC3OFc2KM7:TR?=MXLTRW5ITVJ?
NCI-H1581Mmf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXPJR|UxRTBwMEe0O|gh|ryPMV\TRW5ITVJ?
U-266M1rITmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHUTWM2OD1yLkC3OFk4KM7:TR?=MVvTRW5ITVJ?
DMS-114MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTBwMEe1Nlgh|ryPM1y3RXNCVkeHUh?=
NCI-H187NYD4cldFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmH3TWM2OD1yLkC3O|I3KM7:TR?=M{fmXHNCVkeHUh?=
SW962MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1[1d2lEPTB;MD6wO|g{QSEQvF2=NVfUTWpiW0GQR1XS
MONO-MAC-6NGDuN4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXlfYRKSzVyPUCuNFc6QDZizszNNUnteGY{W0GQR1XS
MOLT-16NVvSdJNFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYDx[ZdTUUN3ME2wMlA5OTJzIN88US=>NX7PNpJ{W0GQR1XS
KNS-42MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mkn2TWM2OD1yLkC4NVYyKM7:TR?=M4DuTXNCVkeHUh?=
CMKM1Xocmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3LRWmlEPTB;MD6wPFIzPSEQvF2=MVTTRW5ITVJ?
Ramos-2G6-4C10MoXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTBwMEiyNlUh|ryPMVzTRW5ITVJ?
DaudiNXPhdIhuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DhTWlEPTB;MD6wPFI2PiEQvF2=NXnUOoxYW0GQR1XS
NCI-H510AM{LMOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2nlR2lEPTB;MD6wPFM{PiEQvF2=NEC3Z|lUSU6JRWK=
LB831-BLCMlmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFv2[lJKSzVyPUCuNFg2PjFizszNNYjWVm9pW0GQR1XS
HELMVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTBwMEi2Olgh|ryPNVPmZoMzW0GQR1XS
LU-134-AM3jiNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnPBTWM2OD1yLkC4O|A5KM7:TR?=NF\yW2lUSU6JRWK=
NCI-H1694M1HVb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPmTWM2OD1yLkC4O|Q1KM7:TR?=MkG5V2FPT0WU
KGNM2K4OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfjTWM2OD1yLkC4O|U6KM7:TR?=NV;U[VdkW0GQR1XS
A253NHXaV5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlm5TWM2OD1yLkC4PFIzKM7:TR?=MXLTRW5ITVJ?
DG-75M4\nVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXCOItZUUN3ME2wMlA5QTJ{IN88US=>MUTTRW5ITVJ?
MOLT-4MkHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3m2d2lEPTB;MD6wPFk5OyEQvF2=NX;BNWdPW0GQR1XS
NCI-SNU-5M3nZV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoGyTWM2OD1yLkC5NlU5KM7:TR?=M{DJTHNCVkeHUh?=
ONS-76M3Hoemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXGxXmFyUUN3ME2wMlA6Ojd4IN88US=>MljVV2FPT0WU
NCI-H446MlHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTBwMEm0OlIh|ryPNWnMd2xDW0GQR1XS
COR-L279NHX1TpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTBwMEm1OVYh|ryPM2HpS3NCVkeHUh?=
Calu-6NV24Z2JPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTBwMEm1PVgh|ryPNFHIbXdUSU6JRWK=
BC-3M3;NRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoLaTWM2OD1yLkC5OlYzKM7:TR?=NUPq[XN4W0GQR1XS
NCI-H2126NYr4[GZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTBwMEm3PVEh|ryPM3fDT3NCVkeHUh?=
NCI-H1882Mn3WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{\rcGlEPTB;MD6wPVgxQSEQvF2=MmW5V2FPT0WU
BB65-RCCMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkO3TWM2OD1yLkGwNlk1KM7:TR?=M1q1U3NCVkeHUh?=
DU-4475NWr5flZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE[4S2tKSzVyPUCuNVA1ODdizszNMXTTRW5ITVJ?
NCI-H526M2LKdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXSfHlKSzVyPUCuNVA1PCEQvF2=MV7TRW5ITVJ?
NEC8Mmf1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{nzW2lEPTB;MD6xNFUzPSEQvF2=MknrV2FPT0WU
NCI-H1304Ml60S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHraTndKSzVyPUCuNVA2QTRizszNNEjCN4hUSU6JRWK=
L-540NInxSZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlr2TWM2OD1yLkGwO|A5KM7:TR?=MorTV2FPT0WU
NCI-SNU-16M3nsUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\GTWM2OD1yLkGwO|QzKM7:TR?=NXexNWJEW0GQR1XS
HD-MY-ZM{DKNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYrV[pkxUUN3ME2wMlExQDV4IN88US=>M4DtN3NCVkeHUh?=
K-562M3Xwb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTBwMUC4OVgh|ryPNGG1dY9USU6JRWK=
JARMlfrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYrJR|UxRTBwMUC5NlUh|ryPNH\4SHRUSU6JRWK=
MZ2-MELNXzUOZNlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVPxNZRSUUN3ME2wMlEyODVizszNNUjZfHAxW0GQR1XS
L-363MnXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknzTWM2OD1yLkGxNFc6KM7:TR?=MVrTRW5ITVJ?
BV-173M4i2Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4W5XGlEPTB;MD6xNVI1OyEQvF2=MlnXV2FPT0WU
NCI-H524NFn6SIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWrRbplzUUN3ME2wMlEyOjd2IN88US=>M3r3[XNCVkeHUh?=
EoL-1-cellMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlPyTWM2OD1yLkGxOlczKM7:TR?=MXXTRW5ITVJ?
K052M37lOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXKwW4M3UUN3ME2wMlEyPzF{IN88US=>MnPEV2FPT0WU
TK10NVO5Z|dJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTBwMUG3Nlgh|ryPM{TV[XNCVkeHUh?=
KU812MkL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\QUWlEPTB;MD6xNlA1PCEQvF2=MUfTRW5ITVJ?
RPMI-8226NXrjU|B5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmjrTWM2OD1yLkGyNFUzKM7:TR?=MomxV2FPT0WU
MZ7-melNUTKd4ZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvPTWM2OD1yLkGyNlM4KM7:TR?=NV7hZWMzW0GQR1XS
SK-PN-DWNFLzUpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4XRe2lEPTB;MD6xNlI5PyEQvF2=MXTTRW5ITVJ?
SRMmrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHPTN4hKSzVyPUCuNVI1PDFizszNNHLvbmJUSU6JRWK=
RPMI-6666M3rKbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37sdGlEPTB;MD6xNlc1OyEQvF2=NH34VGFUSU6JRWK=
no-11NVjnRYtRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2rTfmlEPTB;MD6xNlg3QSEQvF2=NVPlVXZKW0GQR1XS
EW-3MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTBwMUK4PVMh|ryPNGHGOWJUSU6JRWK=
LAMA-84NHj1emtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13KOmlEPTB;MD6xN|E5PyEQvF2=MW\TRW5ITVJ?
HTNFfyW|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3ob4lKSzVyPUCuNVM2PzRizszNNUnwN|VjW0GQR1XS
KP-N-RT-BM-1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml70TWM2OD1yLkGzOlEzKM7:TR?=M2DtUHNCVkeHUh?=
NCI-H747MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlW0TWM2OD1yLkGzO{DPxE1?MmLoV2FPT0WU
NCCITMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkW3TWM2OD1yLkGzPVM6KM7:TR?=MVvTRW5ITVJ?
MLMAMkDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRTBwMUSxOlch|ryPMlXLV2FPT0WU
LP-1MlXmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn2wTWM2OD1yLkG0NlQh|ryPNUnJVo1SW0GQR1XS
CAL-148NWS3XW1RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV7yUXN{UUN3ME2wMlE1PDh|IN88US=>NX61cJlRW0GQR1XS
GB-1MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwMUS1NlYh|ryPMkfXV2FPT0WU
COR-L88MkjIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2nIbmlEPTB;MD6xOFgxOiEQvF2=MmTsV2FPT0WU
NKM-1NFXJcWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnYSnFsUUN3ME2wMlE1QTB4IN88US=>MVfTRW5ITVJ?
NB5NGX5T5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LScmlEPTB;MD6xOVQ3OiEQvF2=NVnFNWJTW0GQR1XS
SH-4MkTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnPTWM2OD1yLkG1OFY3KM7:TR?=NXrl[lk3W0GQR1XS
EM-2MnnRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF3Le3pKSzVyPUCuNVU1PjdizszNMVrTRW5ITVJ?
TGBC24TKBNUPKSFJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTBwMUW2OVkh|ryPNXLSWG03W0GQR1XS
SCLC-21HNXPNW2ZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYK4eIR6UUN3ME2wMlE2PzB{IN88US=>MYjTRW5ITVJ?
COLO-684M{n1Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3vvZmlEPTB;MD6xOVczOSEQvF2=MnjzV2FPT0WU
KINGS-1NVu2fHJVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWLOcpZHUUN3ME2wMlE2QTFizszNMnzVV2FPT0WU
LS-123MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mmi5TWM2OD1yLkG1PVE4KM7:TR?=Ml64V2FPT0WU
MC116MoX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHewRpBKSzVyPUCuNVYyPThizszNNITiUoZUSU6JRWK=
SU-DHL-1M2f4UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3:5[WlEPTB;MD6xOlIxPiEQvF2=M3PHO3NCVkeHUh?=
NCI-H64MkHsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUX2[JByUUN3ME2wMlE3OzR5IN88US=>NX:zbHdkW0GQR1XS
HCE-TM{W0Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3uzXWlEPTB;MD6xOlUxPCEQvF2=NXrJTFZ{W0GQR1XS
LOXIMVIMlrXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHvTWM2OD1yLkG2PVQ6KM7:TR?=MmHJV2FPT0WU
ARH-77MkP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1ThUWlEPTB;MD6xO|M4QSEQvF2=NHroe4tUSU6JRWK=
DOHH-2NEHiXGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HueWlEPTB;MD6xO|Y4OiEQvF2=NFLiN41USU6JRWK=
COLO-320-HSRNIP2S2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4W3VmlEPTB;MD6xPFE2PCEQvF2=NI\yOVFUSU6JRWK=
NB6NGTNc5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\vSWlEPTB;MD6xPFU3PiEQvF2=Ml\zV2FPT0WU
L-428NGS1TYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWrJR|UxRTBwMUi4NVMh|ryPM1SzSHNCVkeHUh?=
SNB75MnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIDoNVdKSzVyPUCuNVg5OjRizszNM1XwVXNCVkeHUh?=
NCI-H2141NVLmV5hkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXXRmZXUUN3ME2wMlE6ODFzIN88US=>NHe0eJBUSU6JRWK=
KARPAS-299NUPKW|V[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwMUmyOFEh|ryPM4S0W3NCVkeHUh?=
LC4-1NWC4dYtnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUn3fXNYUUN3ME2wMlE6PTB{IN88US=>NUGyZlJiW0GQR1XS
UACC-257NF\CZVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjnZmVQUUN3ME2wMlE6QTR5IN88US=>NXLEbYZqW0GQR1XS
EVSA-TM{Ljemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoL2TWM2OD1yLkKwN|EzKM7:TR?=NXHaXYdkW0GQR1XS
JiyoyeP-2003MlvKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnlUIVKSzVyPUCuNlA1PzdizszNNF7KZVRUSU6JRWK=
NCI-H720Ml3mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1PZOGlEPTB;MD6yNFUzPSEQvF2=Ml\rV2FPT0WU
GAKMnX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF3FToVKSzVyPUCuNlEyQDlizszNMlfNV2FPT0WU
HHM1PEO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2DCNGlEPTB;MD6yNVQxPSEQvF2=NXHjRlhDW0GQR1XS
NCI-H1436MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTBwMkG0OlQh|ryPMlWxV2FPT0WU
GR-STNIPvToNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHReVdiUUN3ME2wMlIyPDh6IN88US=>Ml\6V2FPT0WU
BC-1NU\vR41tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGr3foZKSzVyPUCuNlI3OTZizszNNITnV3RUSU6JRWK=
SIG-M5NFPZRoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX7qUJpPUUN3ME2wMlIzPzJ5IN88US=>M4TKSHNCVkeHUh?=
NCI-H345NGHXUVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MljzTWM2OD1yLkKzPFA2KM7:TR?=M4LrN3NCVkeHUh?=
OPM-2MmfPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDkNlRKSzVyPUCuNlM5QDJizszNMWHTRW5ITVJ?
LB1047-RCCMlfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTBwMkS0NUDPxE1?NI\NS29USU6JRWK=
CTB-1M4XoSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\acoRjUUN3ME2wMlI1PDl|IN88US=>NITMSG1USU6JRWK=
A3-KAWNIXEc4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvJNHM5UUN3ME2wMlI2OzRzIN88US=>MVrTRW5ITVJ?
SF126M1;zN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTBwMkWzPFMh|ryPMlO3V2FPT0WU
KARPAS-422MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXrTWM2OD1yLkK1OFM2KM7:TR?=NXLOfZZVW0GQR1XS
MEG-01M3f6PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoraTWM2OD1yLkK1Olc{KM7:TR?=NHTuWJpUSU6JRWK=
NCI-H209M3jVZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTBwMk[zO|Qh|ryPMnm2V2FPT0WU
SBC-1NETQZoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMk[1JO69VQ>?M4fNU3NCVkeHUh?=
K5MkXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NETndlBKSzVyPUCuNlY6QDRizszNM4jDOnNCVkeHUh?=
QIMR-WILMnLYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHTyOGJKSzVyPUCuNlcyPTVizszNMU\TRW5ITVJ?
NMC-G1M37lWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoD6TWM2OD1yLkK4NlE4KM7:TR?=M1\lXXNCVkeHUh?=
IST-MES1MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{O1NWlEPTB;MD6yPVI{QCEQvF2=NXfQO5oxW0GQR1XS
SW684Mm\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1XJTGlEPTB;MD6zNFA1PyEQvF2=MV7TRW5ITVJ?
MV-4-11NF7sbodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTBwM{C3PFgh|ryPMVLTRW5ITVJ?
LAN-6NY\HbVB5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYrqPVJWUUN3ME2wMlMyPTd{IN88US=>M325OnNCVkeHUh?=
RH-1NHrKXFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHKzZo1KSzVyPUCuN|E5PzFizszNNIDWXJdUSU6JRWK=
CP66-MELNVzIfoF{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTBwM{G4O|gh|ryPM4LJPHNCVkeHUh?=
EC-GI-10NWntc2hoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHXKNGFKSzVyPUCuN|I6QDdizszNMXTTRW5ITVJ?
GDM-1Mn;yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGHk[XlKSzVyPUCuN|MxPTlizszNNGLTR2tUSU6JRWK=
IST-SL1MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnJWXBKSzVyPUCuN|Q6OTRizszNNEnyZ5lUSU6JRWK=
KMOE-2NV[4NYhuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEf0NHFKSzVyPUCuN|UyPzVizszNMUfTRW5ITVJ?
OS-RC-2NUOyd3o{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYm4bmJRUUN3ME2wMlM2PTR2IN88US=>M1yxW3NCVkeHUh?=
HDLM-2M{W5ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXXXUIpnUUN3ME2wMlM4QDF2IN88US=>NYfWcpFQW0GQR1XS
DSH1MoK3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MY\JR|UxRTBwM{i2N|Eh|ryPMXrTRW5ITVJ?
LS-1034M3z0[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV;aSIRqUUN3ME2wMlM5QTV2IN88US=>NGrNRZJUSU6JRWK=
LB373-MEL-DNUfN[2hNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPLW3BlUUN3ME2wMlM6OTl5IN88US=>MmDDV2FPT0WU
GOTOM{m0UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXLIU2xwUUN3ME2wMlQzOTF6IN88US=>NUT1RmVFW0GQR1XS
MRK-nu-1NVHtdXN7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVrJR|UxRTBwNEKyNFUh|ryPMmLWV2FPT0WU
SK-MM-2NGTCTWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrJTWM2OD1yLkSzOFQzKM7:TR?=M3\tUHNCVkeHUh?=
BOKUM1joc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTBwNEO3PVIh|ryPNVTEZlJ6W0GQR1XS
NOMO-1NHTwPY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTBwNEO4OkDPxE1?NUfX[Jg1W0GQR1XS
J-RT3-T3-5Ml6zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrmcW9KSzVyPUCuOFQ5PzhizszNMYPTRW5ITVJ?
COLO-668NV64Z4syT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DRR2lEPTB;MD60OVY3QCEQvF2=NWmyZo9{W0GQR1XS
SF539M2PSZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTBwNEi2PFQh|ryPM4TjVnNCVkeHUh?=
LB2518-MELMl;ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTBwNEm3NFMh|ryPNU\ZfW9KW0GQR1XS
TE-441-TM2jmPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7iTWM2OD1yLkWwNVIh|ryPNXjWUHpQW0GQR1XS
MDA-MB-134-VINYLRWYxkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1ezb2lEPTB;MD61NFkzOSEQvF2=MoTIV2FPT0WU
SCC-3NYLZNWZNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTBwNUG4O|Mh|ryPMYrTRW5ITVJ?
KLEMonJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LMdmlEPTB;MD61NlE4OSEQvF2=NILsfplUSU6JRWK=
LB2241-RCCMmHIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFm1R2ZKSzVyPUCuOVI2OjVizszNMUHTRW5ITVJ?
NCI-H1417NIC3eINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3P0PGlEPTB;MD61N|Q{PSEQvF2=NUeyNlBJW0GQR1XS
NCI-H2081NVH1cG45T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1PJZWlEPTB;MD61PFYyOSEQvF2=M2\OZ3NCVkeHUh?=
NCI-H1522M1fTNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTBwNUmzPFMh|ryPNV[y[4ZmW0GQR1XS
NCI-H889MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4fpdGlEPTB;MD61PVg1PCEQvF2=NWPYUotzW0GQR1XS
CGTH-W-1NWLzOpVnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzhTWM2OD1yLk[wO|U2KM7:TR?=NVKwVJFnW0GQR1XS
EB-3MmnrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3VTWM2OD1yLk[xNVU{KM7:TR?=MXzTRW5ITVJ?
D-336MGM3\1V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYO2[YRmUUN3ME2wMlYyPzlzIN88US=>MYPTRW5ITVJ?
LC-1FNHTQfZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3fMPWlEPTB;MD62NlU6OiEQvF2=MWjTRW5ITVJ?
MHH-NB-11M3noeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrjPWVKSzVyPUCuOlM5ODFizszNNE[ybY9USU6JRWK=
SK-N-FIMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mor3TWM2OD1yLk[zPVEh|ryPMmrrV2FPT0WU
NCI-H69M2TDTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\aUGI3UUN3ME2wMlY1QDd7IN88US=>M1XFN3NCVkeHUh?=
SCHMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTBwNk[wNlMh|ryPMmXPV2FPT0WU
LS-513NYHpZ3RjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnTuTWM2OD1yLk[3NlU6KM7:TR?=M2L0[XNCVkeHUh?=
CP67-MELNGrTO2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXTZfnBiUUN3ME2wMlY4PTl4IN88US=>MorCV2FPT0WU
GCIYMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTBwN{CzOlMh|ryPMnOzV2FPT0WU
SHP-77NIPJc5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnLoTWM2OD1yLkewO|M1KM7:TR?=M4TWcXNCVkeHUh?=
EHEBNFLTeXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3vd3ZKSzVyPUCuO|E5PTRizszNNYDwfm5SW0GQR1XS
D-247MGMonhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXhTWM2OD1yLkezNlMzKM7:TR?=NH;6PXZUSU6JRWK=
RajiNHW1R3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUnJR|UxRTBwN{S5PFkh|ryPNFnRbmFUSU6JRWK=
MPP-89Ml3HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHITWM2OD1yLke1PVc5KM7:TR?=NVHtNFgyW0GQR1XS
EKVXM2HJVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2fkeWlEPTB;MD63PVA4OyEQvF2=M3vCcnNCVkeHUh?=
HCC2218M4m5fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTBwN{mxN|Eh|ryPMmfkV2FPT0WU
KNS-81-FDNG\KR4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGntZ3pKSzVyPUCuPFExOTFizszNM3zjN3NCVkeHUh?=
HCC2157MlzaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnMUFZKSzVyPUCuPFQ6PTFizszNMn7XV2FPT0WU
BT-474MoPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDZflhiUUN3ME2wMlg5QDV2IN88US=>MXLTRW5ITVJ?
NCI-H748MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU[5PY97UUN3ME2wMlkyOiEQvF2=MVnTRW5ITVJ?
EW-24MlviS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH74R41KSzVyPUCuPVIxODJizszNNYXPfYZvW0GQR1XS
D-263MGNVvVPYZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIiyfmxKSzVyPUCuPVQ2OTJizszNM172RXNCVkeHUh?=
OMC-1NYnJN5FyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTBwOU[zO|Mh|ryPM1e1WXNCVkeHUh?=
NCI-H2196M4rNTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGewOW9KSzVyPUCuPVc4PzdizszNMnzlV2FPT0WU
HAL-01NXXkb|BIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHSzWlNKSzVyPUCuPVk5PzJizszNNYrh[YRIW0GQR1XS
NCI-H2107NF\ad|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nsPWlEPTB;MT6wNVg2PCEQvF2=MWHTRW5ITVJ?
LB996-RCCMn3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVzW[Y5[UUN3ME2xMlA5ODVzIN88US=>MXnTRW5ITVJ?
NCI-H1395NHHE[XVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3f4WmlEPTB;MT6xNFY4KM7:TR?=MmrqV2FPT0WU
CHP-126M2HYSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NELmUppKSzVyPUGuNVYyQTlizszNMlzYV2FPT0WU
NB69MnfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnztTWM2OD1zLkK2NVQ5KM7:TR?=NXv4SVVmW0GQR1XS
CAS-1NH\NWoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTFwM{SyN|Eh|ryPMX;TRW5ITVJ?
JVM-3NHnIb45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PicWlEPTB;MT60O|g2PSEQvF2=MUHTRW5ITVJ?
DMS-153M3Hkbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXzJR|UxRTFwNUe2O|Qh|ryPM2Pt[nNCVkeHUh?=
SK-MEL-2NF7vRWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnXd4F{UUN3ME2xMlcyPzh7IN88US=>NXzXOZFNW0GQR1XS
NCI-H1155MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1r5[2lEPTB;MT63N|Y4PiEQvF2=NX;scJRZW0GQR1XS
NCI-H1092MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF3LOmRKSzVyPUGuO|YyQDJizszNNWm4[49WW0GQR1XS
LU-165M1z2Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\pTWM2OD1zLki2OFc3KM7:TR?=NYTyRodHW0GQR1XS
HL-60NYXDeW14T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWeyfW5TUUN3ME2xMlk6QTB6IN88US=>NVXJS4ZtW0GQR1XS
REHM3mx[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVv2dphtUUN3ME2yMlAxPTh{IN88US=>NF\YRYlUSU6JRWK=
JVM-2M1T6Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2G5Z2lEPTB;Mj6wOlE{PSEQvF2=MYjTRW5ITVJ?
MN-60MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGe0WY5KSzVyPUKuNVc{ODhizszNNIfZVG5USU6JRWK=
SCC-15NWHJV3A4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NU\J[lVHUUN3ME2yMlIxOjdizszNMXPTRW5ITVJ?
SNU-C1NFzOOZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUf1NYJMUUN3ME2yMlIyOzR|IN88US=>MnnOV2FPT0WU
SK-MEL-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmnUTWM2OD1{LkOyNFQ4KM7:TR?=M2rvU3NCVkeHUh?=
TGWM33LXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWewV25qUUN3ME2yMlM2ODJ5IN88US=>NXez[2pMW0GQR1XS
CA46MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmewTWM2OD1{Lke1PVY4KM7:TR?=MYDTRW5ITVJ?
NCI-H23M17Mb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYrFR41jUUN3ME2yMlgxPzlzIN88US=>NY[2UpdQW0GQR1XS
MMAC-SFMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGXLe2NKSzVyPUKuPFY3OjhizszNMYPTRW5ITVJ?
NCI-H2171NHLWVWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlnDTWM2OD1|LkCzOFQ5KM7:TR?=MWfTRW5ITVJ?
A704NX;RbYg5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HyXmlEPTB;Mz6xOFE6PCEQvF2=M{XuOHNCVkeHUh?=
DBMk\wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTNwMkW1O|Yh|ryPMX\TRW5ITVJ?
NCI-H719M1foeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLTbXF1UUN3ME2zMlMxOzh2IN88US=>MmPRV2FPT0WU
MC-CARM4e3OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{m1SmlEPTB;Mz61OFgyPyEQvF2=NXLZWINKW0GQR1XS
SIMAM{fm[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVK5SFk5UUN3ME2zMlU5PDF4IN88US=>NX7wVnV4W0GQR1XS
SW872MmO1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTNwN{ixNFEh|ryPMmfCV2FPT0WU
HCC1187MljwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLZTWM2OD1|Lke4N|E2KM7:TR?=NFGyU5JUSU6JRWK=
EW-13M4HsW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTNwOEO0NVch|ryPMmnKV2FPT0WU
NCI-SNU-1MoHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX6xSXBRUUN3ME20MlIyQTl7IN88US=>M2DrfXNCVkeHUh?=
NCI-H226M1\NWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\odldDUUN3ME20MlM{PjB4IN88US=>MYnTRW5ITVJ?
RPMI-8866NF:wdJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTRwM{[wNlkh|ryPMli5V2FPT0WU
OCI-AML2MnfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTRwNUWyN{DPxE1?NVGxTG46W0GQR1XS
LU-65MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXHTWM2OD12LkmzNFM{KM7:TR?=NIftWZVUSU6JRWK=
SK-N-DZNUX2N5E4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTVwNkO0OlUh|ryPM4j0SnNCVkeHUh?=
NB14MlzCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXXJR|UxRTVwOUexN|Uh|ryPMmPRV2FPT0WU
COLO-829M{mzbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3i2d2lEPTB;Nj6zN|M2QSEQvF2=M{PHR3NCVkeHUh?=
MHH-CALL-2M{n3cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTZwNUG1NFgh|ryPMoTmV2FPT0WU
NCI-H1770NHrsNY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfZTWM2OD14Lk[2PVA1KM7:TR?=MkLJV2FPT0WU
ECC4MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\mU2lEPTB;Nj64NlE4QSEQvF2=MUjTRW5ITVJ?
A498M1vWSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUO1e4FFUUN3ME22Mlg4OTl{IN88US=>Mnu3V2FPT0WU
DMS-79Ml3RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\0TWM2OD15LkC0OVEzKM7:TR?=M1rVTHNCVkeHUh?=
P30-OHKNUmydVRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHTTTVJKSzVyPUeuNlE6ODZizszNNV7BU2tsW0GQR1XS
D-502MGMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3rFbmlEPTB;Nz65PFM3KM7:TR?=MkjqV2FPT0WU
RCC10RGBNUj4XJlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXZTWM2OD16LkC2Nlgh|ryPNEC5dZVUSU6JRWK=
U-698-MNEPrZ29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1f2O2lEPTB;OD6yPVIzPiEQvF2=NHPXc2dUSU6JRWK=
BB49-HNCMkHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVvxdJN2UUN3ME25MlQzOjZ3IN88US=>M3;CNXNCVkeHUh?=
ES1M2TldGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2m0e2lEPTB;OT62PFk2PiEQvF2=NVnDfYFmW0GQR1XS
MFM-223M2nRUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTFyLkm5Nlch|ryPNEXlZ4pUSU6JRWK=
C2BBe1NGToRmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7rfnlKSzVyPUGxMlM2OjNizszNMlvsV2FPT0WU
EB2MnTiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH;uZ4NKSzVyPUGyMlY5QDFizszNNUX1eW1CW0GQR1XS
C8166M1nhZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;QfJNKSzVyPUGzMlg{ODNizszNNYnSemdFW0GQR1XS
ES3MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTF|Lkm5O|ch|ryPNXzzPFY4W0GQR1XS
NCI-H1650MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWftfVV1UUN3ME2xOk4{PzZ3IN88US=>NY\vXpY{W0GQR1XS
Mo-TNXTySmc3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zib2lEPTB;MUeuOFAzQSEQvF2=NUjG[5dbW0GQR1XS
NB7NXXlWodrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jUbGlEPTB;MUeuO|Q3PyEQvF2=NGDqbJhUSU6JRWK=
ES7NWLyfJVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHPblBKSzVyPUG5MlU2ODdizszNM2KwVXNCVkeHUh?=
ES5M3jSXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTJzLke2O|Eh|ryPNEnwWFlUSU6JRWK=
MSTO-211HMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnEOWJKSzVyPUKxMlg5PThizszNNWDlfYh[W0GQR1XS
U-87-MGMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIfC[WFKSzVyPUK1MlE6PjZizszNMlnQV2FPT0WU
THP-1MkLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4SydGlEPTB;MkmuO|IxOSEQvF2=M2nZSnNCVkeHUh?=
NB10MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYfX[mJ7UUN3ME2zNE4zPjl2IN88US=>M2nD[HNCVkeHUh?=
NH-12NUHveGJMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTN|LkKwNVch|ryPNIDHRYNUSU6JRWK=
COLO-824Mk\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnHepNKSzVyPUO0MlExODZizszNMV\TRW5ITVJ?
SKM-1M1nqWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonDTWM2OD1|Nz64OFIzKM7:TR?=NWDBboxDW0GQR1XS
NCI-H1838MmnnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoTUTWM2OD1|OD6zO|k4KM7:TR?=NFPjTYFUSU6JRWK=
RLNEPHRW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVGwNmhDUUN3ME2zPU4zPDd5IN88US=>M3XTN3NCVkeHUh?=
COLO-800MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jiemlEPTB;NECuNFc4OyEQvF2=MkG2V2FPT0WU
KG-1Mn\pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTRyLki5OVUh|ryPMnm4V2FPT0WU
TURNWDMbHFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTRzLk[zPVkh|ryPM3fOcXNCVkeHUh?=
LNCaP-Clone-FGCMkHNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rJdGlEPTB;NEGuPVAyPyEQvF2=MXHTRW5ITVJ?
NCI-H322MMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLxNWN4UUN3ME20Nk42QTh2IN88US=>NXW5XWE4W0GQR1XS
LNCaP M1fmZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fDNGlEPTB;OUGuN{BvVQ>?MknONlU2ODVzN{S=
C4-2MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEL2VIZKSzVyPUigcm0>Mom5NlU2ODVzN{S=
JURKATNYfLfY15T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFS5R3UzPCCqMVHJR|UxRTRzNj62OkBvVQ>?Mn3ONlQ2OTl7OUW=
MOLT-4M3fwVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXqyOEBpMn;CTWM2OD1{OEWzMlUhdk1?M3rNV|I1PTF7OUm1
REHNHWxfpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYfpU3pFOjRiaB?=M3i2NmlEPTB;Mki3MlY5KG6PMkTJNlQ2OTl7OUW=
NALM-6NXT1VpBXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TJT|I1KGh?MlSwTWM2OD1|NEOzNEBvVQ>?M3PmZlI1PTF7OUm1
RS 4;11NYnDPVcyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW[2emttOjRiaB?=Ml3uTWM2OD13MUmuNFUhdk1?MmnwNlQ2OTl7OUW=
697MmrjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1TWOFI1KGh?M{HPfmlEPTB;MkGwO{4yKG6PMk\oNlQ2OTl7OUW=
SIL-ALLNIm2RVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVziRWJMOjRiaB?=NEnDTVJKSzVyPUG5PU44PyCwTR?=NXe1b21KOjR3MUm5PVU>
CEMNEXycFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHPUHIzPCCqMmrVTWM2OD13Mj6xPEBvVQ>?M3y0d|I1PTF7OUm1
P12M124T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHUNlQhcA>?NYrKeoJjUUN3ME2zPU4zPyCwTR?=NF;ldpgzPDVzOUm5OS=>
NALM-16M{Hyc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnDXYczPCCqMY\JR|UxRTl4LkK4JI5OM3jicFI1PTF7OUm1
JURKATNF;wT4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXPk[IhEPDhiaB?=NEXueHZKSzVyPUG0Mlg1KG6PM3LUT|I1PTF7OUm1
MOLT-4MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX7ZNot5PDhiaB?=NFnGR4VKSzVyPUK2MlYhdk1?MoPpNlQ2OTl7OUW=
REHMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTsWY1VPDhiaB?=MoXjTWM2OD12ND63NUBvVQ>?MmjyNlQ2OTl7OUW=
NALM-6MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXO0PEBpMkT4TWM2OD1{Mz6yOkBvVQ>?NGLuTIszPDVzOUm5OS=>
RS 4;11M2O5W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M122XlQ5KGh?MWLJR|UxRTF4ND6yPEBvVQ>?MYGyOFUyQTl7NR?=
697NUHYTIFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEOzR4c1QCCqMX3JR|UxRTNyNT6zJI5OM2PwPFI1PTF7OUm1
SIL-ALLMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVrZd4JlPDhiaB?=NUXVWZlpUUN3ME23OE43OiCwTR?=NYS2bY9lOjR3MUm5PVU>
CEMM4G1R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGLvV4Y1QCCqMom2TWM2OD1{ND61OUBvVQ>?NF\0WWozPDVzOUm5OS=>
P12Mmf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVi0PEBpMXLJR|UxRTF6LkS2JI5OMoi2NlQ2OTl7OUW=
NALM-16NXT2fGlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NITRW2o1QCCqNXS2VFBbUUN3ME22N{4zPCCwTR?=M1m5TVI1PTF7OUm1
JURKATNGGyUIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{\JWlczKGh?NXzWN4RVUUN3ME2zMlY2KG6PM1XOd|I1PTF7OUm1
MOLT-4M2PoOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEi4[IM4OiCqM2HQfWlEPTB;Nz6zPUBvVQ>?NEP4RVgzPDVzOUm5OS=>
REHM37yTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrqeZlqPzJiaB?=NXnqc4ltUUN3ME2xOk4xOSCwTR?=MX2yOFUyQTl7NR?=
NALM-6NIezco5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlnmO|IhcA>?MnjFTWM2OD1zLke4JI5ONUXVPJRjOjR3MUm5PVU>
RS 4;11NFG3dYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\0O|IhcA>?Mm\oTWM2OD12LkO4JI5OM{ToSFI1PTF7OUm1
697M1PNcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHL1b4w4OiCqM4DLZWlEPTB;N{SuNlghdk1?NXLFVmlHOjR3MUm5PVU>
SIL-ALLMnHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7ae2ZtPzJiaB?=NH24XIhKSzVyPUeuNkBvVQ>?MlTkNlQ2OTl7OUW=
CEMMljzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVmwcmd5PzJiaB?=M1jGU2lEPTB;NT60NkBvVQ>?NXHiVYlOOjR3MUm5PVU>
P12NHvnXZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVu5T4lIPzJiaB?=MV3JR|UxRTZwM{egcm0>M1fzO|I1PTF7OUm1
NALM-16MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXYS4o4OiCqMVvJR|UxRTd5LkezJI5ONHn6OoMzPDVzOUm5OS=>
Y79NYPJd3A3SXCxcITvd4l{KEG|c3H5MWSxMVUxKG6PM{mxSlEzNzJ2IHi=NYXReHlxTE2VTx?=NF\BWHpqdmS3Y3XkJIFxd3C2b4Ppd{B4cGmlaDDjZY4h[mViZX7oZY5k\WRiYomgTHQ>MUSyOFM3PjZ4NR?=
WER-Rb-1MoWzRZBweHSxc3nzJGF{e2G7Mn7rNU02OCCwTR?=NVHQ[XRlOTJxMkSgbC=>NVXhd3k2TE2VTx?=NYTsXVN7cW6mdXPl[EBieG:ydH;zbZMhf2irY3igZ4FvKGKnIHXubIFv[2WmIHL5JGhVNEj4SpkzPDN4Nk[2OS=>
G7MojZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XrXWlEPTB;Mz6zJI5OMmrYNlQzODR5M{O=
G166MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPLTWM2OD15LkCgcm0>MU[yOFIxPDd|Mx?=
CB660NED1TJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1:5dWlEPTB;Nj60JI5OM1flOVI1OjB2N{Oz
CB1117NFfaW2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XwOWlEPTB;MUWuOkBvVQ>?MXeyOFIxPDd|Mx?=
KB-3-1NWjtTI9vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWnKTYltUUN3ME2xMlQ5KMLzIECuOVMhdk1?M3;wOlI{QTZ{NES1
KB-8-5-11NX7vdoJzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnje29bUUN3ME21MlAyKMLzIEKuNFEhdk1?MVyyN|k3OjR2NR?=
KB-C-1NETwVmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVTLPW46UUN3ME2xOk44PiEEsTC0MlUyKG6PMnrQNlM6PjJ2NEW=
KB-V-1NWL1RlBmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIi0V3pKSzVyPUK4NU4zPCEEsTCzNU42PyCwTR?=NFOwOXozOzl4MkS0OS=>
OVCAR-8MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFf3O3dKSzVyPUeuNVkhyrFiMz62NEBvVQ>?MknNNlM6PjJ2NEW=
NCI-ADR-RESNFjuUXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\pW3pKSzVyPUGyO|MvOzBiwsGgNVkyNjJyIH7NMXOyN|k3OjR2NR?=
MCF7NGfpTVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;IPZZKSzVyPUWuNVEhyrFiMT60O{BvVQ>?M3rtbFI{QTZ{NES1
MCF7-FLV1000NHi3SmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnuWoFKSzVyPUO5N{4yQCEEsTC3OE45OyCwTR?=M33mOlI{QTZ{NES1
S1Mmn3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWnjSnhXUUN3ME2yOE4{OCEEsTC0Mlc2KG6PMYqyN|k3OjR2NR?=
S1-M1-80MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTJ4MT6wOkDDuSB2OD6yOUBvVQ>?NFfkdpczOzl4MkS0OS=>
CORL-23/PM3LOfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHBTWM2OD12LkO4JOKyKDFwMkWgcm0>MknpNlM6PjJ2NEW=
CORL-23/RNEGx[FFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2ewTGlEPTB;NT6xOkDDuSBzLkizJI5OM3K4N|I{QTZ{NES1
NIH3T3MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;2PWlEPTB;NECuOlAhyrFiND65O{BvVQ>?M130NlI{QTZ{NES1
NIH3T3-G185NYjid2pVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPNTWM2OD1{NEGzMlQxKMLzIESyN{43PiCwTR?=NUS3d49uOjN7NkK0OFU>
pcDNA-HEK293M2\NXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFraOoVKSzVyPUKuO|UhyrFiMD62O{BvVQ>?MoTkNlM6PjJ2NEW=
MDR19-HEK293Mly0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXzfHVKSzVyPUi1MlUxKMLzIEGzMlY4KG6PNFnYcogzOzl4MkS0OS=>
R482-HEK293Ml3VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTnXmtKSzVyPUK1Mlk4KMLzIESuPVUhdk1?NHLMSXAzOzl4MkS0OS=>
MRP1-HEK293MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1Ha[2lEPTB;Mj65PUDDuSBzLkS5JI5ONUTQ[4JrOjN7NkK0OFU>
SF188MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVuxNE0yODBibl2=MoD3NlQuQTZiaB?=NX[xWnluTE2VTx?=MmDNbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYn;0bEB1cW2nLTDhcoQh[2:wY3XueJJifGmxbj2g[IVx\WSnboSgcYFvdmW{MojoNlM5QDd4NEW=
T98GM1nV[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUKxNE0yODBibl2=NGTIcoozPC17NjDoM2PTWWROW09?M4PkZolvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHPvcoNmdnS{YYTpc44uKGSncHXk[Y51KG2jbn7ldi=>NYf5XohGOjN6OEe2OFU>
DU145NWDQdG1YT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUS3cpJvTE2VTx?=NFn3VlVKSzVy4pk8OlAhdk1?M4T2UFI{QDh2NEK4
LNCaP NWK4Nlk4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV63cG17TE2VTx?=NX7oOVhCUUN3MPMIwFc2KG6PM2LKOlI{QDh2NEK4
PC3M4nvbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1XEcGROW09?M{TmXmlEPTEkiMyxO|Uhdk1?NGi5TJQzOzh6NESyPC=>
RT4NYnCelVbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTJ5LkKxJI5OMl\QNlM4QTJ4M{m=
5637NWXOS2p{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTR3LkS3JI5ONWTFUldwOjN5OUK2N|k>
T24MoWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFfKXIZKSzVyPUe5MlEzKG6PM2G4W|I{Pzl{NkO5
MCF7 NFnofo5HfW6ldHnvckBCe3OjeR?=MoDTNVAxKG6PNVjq[XBpOSCqNWTQWGNiTE2VTx?=MofCdoVlfWOnczD0bIUhcW6mdXP0bY9vKG:owrDHdoVjOS{EoGPnb|EtyqCSc{KsxsBU\XKyaX7hN{wh[W6mwrDXbZNxOg>?NYe4U|h2OjN5N{CyOFQ>
KB-V1 NY\SXJNkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoLkTWM2OD1|LkmyJO69VQ>?NILRXWszOzV7M{G5Oi=>
Hec50coM4LHZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIj6RZJKSzVyPUWgcm0>M4K4R|I{OTR4Nki3
MDA-MB-468Mk\oRZBweHSxc3nzJGF{e2G7NXi2W21TOS93L{GwJI5ONInJbYEzPC92OD:3NkBpM1r0e2ROW09?M2rINIlv\HWlZYOgZZBweHSxc3nzJIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXyMXuyN|E1PDJ7NB?=
MCF10AMl:wRZBweHSxc3nzJGF{e2G7MV[xM|UwOTBibl2=MV[yOE81QC95MjDoNUiySnpXTE2VTx?=NWi3emFIcW6mdXPld{BieG:ydH;zbZMhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI>NYDhZolFOjNzNESyPVQ>
Huh-7MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M370UlEwOTBxMUCwM|ExODBibl2=M2H0XFQ5KGh?NFTXfFBl\WO{ZXHz[ZMhfGinIHPlcIwhfmmjYnnsbZR6KGSxc3Wt[IVx\W6mZX70cJk>NXjkVI9vOjJ5NEW1PFc>
Daoy M1\Cc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mki5NU45PzVvMkSwJI5OMU[3NkBpNYLLfo9GTE2VTx?=M3XzT2lEPTB;NTDuUS=>NGPDNIszOjN7MEK3PS=>
ONS-76NF7LbXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PIcVEvQDd3LUK0NEBvVQ>?M4nuZVczKGh?NXvkV21STE2VTx?=MYrJR|UxRTdwNTDuUS=>NGjtS3kzOjN7MEK3PS=>
SUM 149NVfXe3BjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;6NE0yODBibl2=NUmwXnNoPzJiaB?=NULjTW5JcW6qaXLpeJMhfGinIHPlcIwhfmmjYnnsbZR6KGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoFzNF:5[mwzOjNyOUmzPS=>
MDA-MB-231MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHiNE0yODBibl2=MVO3NkBpMVfpcohq[mm2czD0bIUh[2WubDD2bYFjcWyrdImgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wYYK=M2rqOVIzOzB7OUO5
HR5M2T2O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUKwMVExOCCwTR?=M4LUfFczKGh?NXjjWlIycW6qaXLpeJMhfGinIHPlcIwhfmmjYnnsbZR6KGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoFzMmCwNlI{ODl7M{m=
BT-474-M1NVXaSlRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXOwMVExOCCwTR?=MoXuO|IhcA>?MlnubY5pcWKrdIOgeIhmKGOnbHygeoli[mmuaYT5JIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnHyM1u5OlIzOzB7OUO5
AU565NVWwb4ZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX3zZ2pzOC1zMECgcm0>M2Lle|czKGh?MVHpcohq[mm2czD0bIUh[2WubDD2bYFjcWyrdImgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wYYK=NGHtUFYzOjNyOUmzPS=>
T47DMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWiwMVExOCCwTR?=MojVO|IhcA>?M2rob4lvcGmkaYTzJJRp\SClZXzsJJZq[WKrbHn0fUBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7hdi=>NHO4dHMzOjNyOUmzPS=>
MCF7NWnGdGRUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUWwMVExOCCwTR?=NH7hbpc4OiCqM{\aPIlvcGmkaYTzJJRp\SClZXzsJJZq[WKrbHn0fUBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7hdi=>NWfs[XNkOjJ|MEm5N|k>
HCT116p53(+/+)MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUGxNE0yODByIH7NMWiyOE81QCCqNFjMcZVqdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44h[2:vcHzleIVtgSCjdDCyOUBvVQ>?M{XNOlIzOjZ{MUex
HCT116p53(-/-)MonVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV\WeGJCOTBvMUCwNEBvVQ>?NF\lTW0zPC92ODDoNYHIZXo4cW6qaXLpeJMh[2WubDDwdo9tcW[ncnH0bY9vKGOxbYDs[ZRmdHliYYSgNlUhdk1?NFKy[IQzOjJ4MkG3NS=>
HeLa Ml3uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVWxNE0yODBibl2=NWG2PWx{PDhiaB?=MmrxSG1UVw>?M2DvTGlEPTB;NUKuPUBvVQ>?M2LLc|IzODhyMkO1
HeLa MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLCNVAuOTByIH7NMY[3NkBpMmPqSG1UVw>?M1rN[2lEPTB;NUCuOUBvVQ>?NEOyXIIzOjB6MEKzOS=>
GBCNX3LVmNUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fmOVczKGh?NHPaRVRKSzVyPUG0Mlc5KG6PMV6yNVk3PTd|OR?=
GB-CL-1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXPO|IhcA>?M2ThS2lEPTB;NT6yNkBvVQ>?MmHvNlE6PjV5M{m=
Mz-ChA-2Mlr0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnwb4Y4OiCqM3znR2lEPTB;Mz6zNUBvVQ>?NYe1NGdWOjF7NkW3N|k>
TGBC1-TKBM{nWXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M16ySVE1PCCqNXLzWYVsUUN3ME22MlczKG6PMYCyNVk3PTd|OR?=
WittierMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUW3NkBpNV\id5NHUUN3ME2zMlI3KG6PNVXYdGp5OjF7NkW3N|k>
H-1M1jkZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUO3NkBpNFTOVoxKSzVyPUmuOVQhdk1?NF2zNYczOTl4NUezPS=>
HuH-28MmDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYrzc2NOPzJiaB?=M3:4NWlEPTB;MUGuNVkhdk1?NInNUY8zOTl4NUezPS=>
NECMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUi3NkBpNHracopKSzVyPUmuPVghdk1?NITyPYozOTl4NUezPS=>
REBMmrMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWq5bYtJPzJiaB?=MnPMTWM2OD1zMz61NUBvVQ>?MW[yNVk3PTd|OR?=
CC-LP-1MkS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7xe4c4OiCqNI[wVGlKSzVyPUWuPFQhdk1?M3znbFIyQTZ3N{O5
CC-SW-1MmThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGfhO4w4OiCqNVHFNIk{UUN3ME25MlU2KG6PM3HjNlIyQTZ3N{O5
EGI-1MnztS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnG3O|IhcA>?NEHtbohKSzVyPUGwMlczKG6PNFvFSpAzOTl4NUezPS=>
Sk-ChA-1Mn3iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWmyUJBsPzJiaB?=NWn0R4hzUUN3ME2xO{4zKG6PNEG2VpEzOTl4NUezPS=>
TFK-1M4HES2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIjIc|E4OiCqMnT1TWM2OD1zMz60OUBvVQ>?MmX6NlE6PjV5M{m=
786-ONIrJW41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13BOVUuQDBibl2=MnX2PVYhcA>?MX7IR4w>MnLid5VxeHKnc4Pld{B1cGVicILvcIln\XKjdHnvckBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldkB4cXSqIFnDOVDDqH[jbIXld{Bw\iB{IITvJFIxKG6PNXj0W4VjOjF4NEKzO|Q>
A498NYHObZE2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkmyOU05OCCwTR?=M1\NPFk3KGh?MlvqTGNtMnPhd5VxeHKnc4Pld{B1cGVicILvcIln\XKjdHnvckBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldkB4cXSqIFnDOVDDqH[jbIXld{Bw\iB{IITvJFIxKG6PNUm2S3pQOjF4NEKzO|Q>
ACHNMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYC1MVgxKG6PNGHxcG46PiCqNV3nU2kzUEOuMVfzeZBxemW|c3XzJJRp\SCycn;sbYZmemG2aX;uJIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXyJJdqfGhiSVO1NOKhfmGudXXzJI9nKDJidH:gNlAhdk1?MVmyNVY1OjN5NB?=
Caki-1NY\kVlZQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPNOU05OCCwTR?=M3Tlb|k3KGh?NVWyXXlQUEOuNH33UJB{fXCycnXzd4V{KHSqZTDwdo9tcW[ncnH0bY9vKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVzKHerdHigTWM2OMLidnHseYV{KG:oIEKgeI8hOjBibl2=MlTYNlE3PDJ|N{S=
SN12CNXW2boFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUGzWJFGPS16MDDuUS=>M1PMOlk3KGh?MmXGTGNtM4LBbpN2eHC{ZYPz[ZMhfGinIIDyc4xq\mW{YYTpc44hcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZIhf2m2aDDJR|UxyqC4YXz1[ZMhd2ZiMjD0c{AzOCCwTR?=MYmyNVY1OjN5NB?=
HMC-1.1MkXoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\helEuOTByMDDuUS=>NYO4Omc3PzJiaB?=MYjpcohq[mm2czD0bIUh[2WubDDwdo9tcW[ncnH0bY9vKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoU>NGnFR2ozOTJ2MkG4PS=>
HMC-1.2MmC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TX[|EuOTByMDDuUS=>NV25fHRnPzJiaB?=MmjxbY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdiCrbjDhJIRwe2VvZHXw[Y5l\W62IH3hco5mMWeyNVI1OjF6OR?=
C2M3rxcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWixMVExODBibl2=Ml7NO|IhcA>?NWK2fnR1cW6qaXLpeJMhfGinIHPlcIwheHKxbHnm[ZJifGmxbjDpckBiKGSxc3Wt[IVx\W6mZX70JI1idm6nM3fIblIyOjR{MUi5
CHP-212MkS2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFrRTo0yNTF{NTDuUS=>NWr0cmh1OjRvMUKwJIg>NXLWOWRmcW6qaXLpeJMhfGinIHPlcIwheHKxbHnm[ZJifGmxbjDpckBjd3SqIITpcYUuKGGwZDDkc5NmNWSncHXu[IVvfCCvYX7u[S=>NWDnSmViOjFzNkmyOFI>
IMR-32Ml7US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUGxMVEzPSCwTR?=MmLPNlQuOTJyIHi=Ml\nbY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdiCrbjDic5RpKHSrbXWtJIFv\CCmb4PlMYRmeGWwZHXueEBu[W6wZR?=NHXGeoIzOTF4OUK0Ni=>
KellyM1fye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfJSlVCOS1zMkWgcm0>NIDyZW0zPC1zMkCgbC=>NUTUd2dCcW6qaXLpeJMhfGinIHPlcIwheHKxbHnm[ZJifGmxbjDpckBjd3SqIITpcYUuKGGwZDDkc5NmNWSncHXu[IVvfCCvYX7u[S=>NYrJOoNIOjFzNkmyOFI>
SH-EPM1PnVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW[xVoZmOS1zMkWgcm0>NWDGZnJmOjRvMUKwJIg>NHv1WW9qdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:wIHnuJIJwfGhidHnt[U0h[W6mIHTvd4Uu\GWyZX7k[Y51KG2jbn7lNELye|MzOTF4OUK0Ni=>
SH-SY5YMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWKxMVEzPSCwTR?=Ml24NlQuOTJyIHi=Mm[wbY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdiCrbjDic5RpKHSrbXWtJIFv\CCmb4PlMYRmeGWwZHXueEBu[W6wZR?=M1f0V|IyOTZ7MkSy
SK-N-ASM365[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYqxMVEzPSCwTR?=MUWyOE0yOjBiaB?=M2TjXIlvcGmkaYTzJJRp\SClZXzsJJBzd2yrZnXyZZRqd25iaX6gZo91cCC2aX3lMUBidmRiZH;z[U1l\XCnbnTlcpQhdWGwbnW=MkjDNlEyPjl{NEK=
SK-N-BENED2UmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVGxMVEzPSCwTR?=MmOxNlQuOTJyIHi=M1Lsc4lvcGmkaYTzJJRp\SClZXzsJJBzd2yrZnXyZZRqd25iaX6gZo91cCC2aX3lMUBidmRiZH;z[U1l\XCnbnTlcpQhdWGwbnW=M{TKUFIyOTZ7MkSy
KG1MofRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\INU8yOC9zMECgcm0>M3TZd|czKGh?M1nt[GROW09?NEfyTXZqdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:wIHnuJIJwfGhidHnt[U0h[W6mIHTvd4Uu\GWyZX7k[Y51KG2jbn7lM{XpSFE6PDV6M{W4
U937NYXsdo5TT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUWyN4hrOS9zMD:xNFAhdk1?NF61elY4OiCqMYXEUXNQNEPsRnZqdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:wIHnuJIJwfGhidHnt[U0h[W6mIHTvd4Uu\GWyZX7k[Y51KG2jbn7lNIDuVVgyQTR3OEO1PC=>
CAL62NFn2WmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYmwMlEuOTByIH7NMXG3NkBpNF7ETYJFVVORMl\sSWM2OD1zLkSgcm0>M{fzR|E6OjJ|NUWz
OCUT-1MonxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVuwMlEuOTByIH7NMkXEO|IhcA>?M37DPWROW09?MUXFR|UxRTJwMzDuUS=>NXTDeGo6OTl{MkO1OVM>
8505CMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGTXfm8xNjFvMUCwJI5OMV[3NkBpM4\oXGROW09?NUHSSXY1TUN3ME2zMlIhdk1?NHvZS|YyQTJ{M{W1Ny=>
ACT-1NYizfmtnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPzNE4yNTFyMDDuUS=>Mln0O|IhcA>?MmfESG1UVw>?NUDjfHd2TUN3ME21MlQhdk1?NHK3XVQyQTJ{M{W1Ny=>
SW1736MoH3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfLNnIxNjFvMUCwJI5OMWK3NkBpNVXT[FBFTE2VTx?=NIP3bXFGSzVyPUWuOkBvVQ>?MUOxPVIzOzV3Mx?=

... Click to View More Cell Line Experimental Data

In vivo BI 2536 given i.v. once or twice per week is highly efficacious in diverse xenograft models with acceptable tolerability by inhibiting cell proliferation through a mitotic arrest, and subsequently induction of tumor-cell death. Administration of BI 2536 at 50 mg/kg once or twice per week significantly inhibits growth of HCT 116 xenografts with T/C of 15% and 0.3%, respectively. BI 2536 treatment twice-weekly also leads to excellent tumor-growth in BxPC-3 and A549 models with T/C of 5% and 14%, respectively. [1]
Features The first potent and selective Plk1 inhibitor that induces all hallmarks of Plk1 inhibition.

Protocol(Only for Reference)

Kinase Assay: [1]

Plk1 in vitro kinase assay Recombinant human Plk1 (residues 1-603) is expressed as N-terminal, GST-tagged fusion protein with a baculoviral expression system and purified by affinity chromatography with Glutathione-agarose. Enzyme activity assays for Plk1 are performed in the presence of serially diluted BI 2536 with 20 ng of recombinant kinase and 10 μg casein from bovine milk as the substrate. Kinase reactions are performed in a final volume of 60 μL for 45 minutes at 30 °C (15 mM MgCl2, 25 mM MOPS [pH 7.0], 1 mM DTT, 1% DMSO, 7.5 mM ATP, 0.3 μCi γ-33P-ATP). Reactions are terminated by the addition of 125 μL of ice-cold 5% TCA. After transfer of the precipitates to Multi-Screen mixed ester cellulose filter plates, plates are washed with 1% TCA and quantified radiometrically. Dose-response curve is used for calculating IC50 value.

Cell Assay: [1]

Cell lines HeLa, A43, SKOV-3, HT-29, K562, A549, Saos-2, MCF7, HCT116, COLO 205, Hep G2, Raji and PC-3 cells, etc.
Concentrations Dissolved in DMSO, final concentrations ~1 μM
Incubation Time 24 and 72 hours
Method Cells are exposed to various concentrations of BI 2536 for 24, and 72 hours. Cell growth is assessed by the measurement of Alamar Blue dye conversion in a fluorescence spectrophotometer. For determining the DNA content of the cultures, cell suspensions are fixed in 80% ethanol, treated for 5 minutes with 0.25% Triton X-100 in PBS, and incubated with 0.1% RNase and 10 μg/mL propidium iodide (PI) in PBS for 20 minutes at RT. Cell-cycle profiles are determined by flow cytometric analysis.

Animal Study: [1]

Animal Models Female BomTac:NMRI-Foxn1nu mice injected subcutaneously with HCT 116, NCI-H460, or A549 cells
Formulation Formulated in hydrochloric acid (0.1 N), and diluted with 0.9% NaCl
Dosages ~50 mg/kg
Administration Injection i.v. once or twice per week

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Steegmaier M, et al. Curr Biol, 2007, 17(4), 316-322.

[2] Nappi TC, et al. Cancer Res, 2009, 69(5), 1916-1923.

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT00526149 Completed Breast Cancer|Endometrial Cancer|Head and Neck Cancer|Melanoma (Skin)|Ovarian Cancer|Sarcoma European Organisation for Research and Treatment of Cance  ...more European Organisation for Research and Treatment of Cancer - EORTC July 2007 Phase 2
NCT02215044 Terminated Pancreatic Neoplasms Boehringer Ingelheim June 2007 Phase 1
NCT00412880 Completed Carcinoma, Small Cell Boehringer Ingelheim January 2007 Phase 2
NCT02211833 Completed Carcinoma, Non-Small-Cell Lung Boehringer Ingelheim October 2006 Phase 1
NCT00701766 Completed Leukemia, Myeloid, Acute Boehringer Ingelheim October 2006 Phase 2

view more

Chemical Information

Download BI 2536 SDF
Molecular Weight (MW) 521.66
Formula

C28H39N7O3

CAS No. 755038-02-9
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 21 mg/mL (40.25 mM)
Ethanol 100 mg/mL (191.69 mM)
Water <1 mg/mL (<1 mM)
In vivo 30% PEG 400+0.5% Tween 80+5% Propylene glycol 15mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name (R)-4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

Frequently Asked Questions

  • Question 1
    We need to use BI 2536 in preclinical studies using mice, how to formulate the inhibitor for this in vivo study?

    Answer: For in vivo study, DMSO should not be more than 5% because the toxicity. You can formulated BI2536 in hydrochloric acid (0.1 N), and diluted with 0.9% NaCl for animal study according to the reference :( Supplemental Data) http://linkinghub.elsevier.com/retrieve/pii/S0960-9822(06)02671-6

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related PLK Products

  • SBE 13 HCl

    SBE 13 HCl is a potent and selective PLK1 inhibitor with IC50 of 200 pM, >4000-fold selectivity over Aurora A kinase, Plk2 and Plk3.

  • Ro-3306

    RO-3306 is an ATP-competitive, and selective CDK1 inhibitor with Ki of 20 nM, >15-fold selectivity against a diverse panel of human kinases.

  • CCG-1423

    CCG-1423 is a specific RhoA pathway inhibitor, which inhibits SRF-mediated transcription.

  • Rigosertib (ON-01910)

    Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.

  • HMN-214

    HMN-214 is a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

  • GSK461364

    GSK461364 inhibits purified Plk1 with Ki of 2.2 nM in a cell-free assay. It is more than 1000-fold selective against Plk2/3. Phase 1.

    Features:Demonstrates >390-fold selectivity for Plk1 relative to Plk2 and Plk3.

  • Volasertib (BI 6727)

    Volasertib (BI 6727) is a highly potent Plk1 inhibitor with IC50 of 0.87 nM in a cell-free assay. It shows 6- and 65-fold greater selectivity against Plk2 and Plk3. Phase 3.

    Features:A high volume of distribution, indicating good tissue penetration, and a long terminal half-life.

  • MLN0905

    MLN0905 is a potent inhibitor of PLK1 with IC50 of 2 nM.

  • Ro3280

    RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.

    Features:A selective PLK1 inhibitor. Demonstrates greater potency than BI2536. Potential use in nasopharyngeal carcinomas.

  • NMS-P937 (NMS1286937)

    NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.

Recently Viewed Items

Tags: buy BI 2536 | BI 2536 supplier | purchase BI 2536 | BI 2536 cost | BI 2536 manufacturer | order BI 2536 | BI 2536 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us